Latest DGX news

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Zacks Investment Research · Wed, 23 Sep 2026 10:41:19 -0400

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Quest Diagnostics Incorporated: Testing Growth Keeps Me Bullish Despite Medicare Headwinds

Seeking Alpha · Wed, 23 Sep 2026 08:50:51 -0400

Quest Diagnostics Incorporated's recurring testing demand provides a foundation for growth through hospital partnerships, dialysis services, and advanced diagnostics. Their dialysis testing and advanced diagnostics add growth opportunities, although their value ultimately depends on execution and reimbursement. So far, DGX's cash flows seem to be benefiting from the acquisition strategy, but if this falters, it may lead to write-downs of its sizable goodwill on the balance sheet.

Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026

PRNewsWire · Tue, 22 Sep 2026 16:28:00 -0400

SECAUCUS, N.J., Sept. 22, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report its third quarter 2026 financial results on Thursday, October 22, 2026, before the market opens.

Why Quest Diagnostics Holdings Stock Dropped Today

The Motley Fool · Tue, 22 Sep 2026 11:37:47 -0400

Medicare and Medicaid have been overpaying Quest Diagnostics for years, says the government. Starting next year, they plan to cut reimbursement of lab testing by 15%.

Quest Diagnostics Study Finds High Tick-Borne Disease Co-Exposure

Zacks Investment Research · Tue, 22 Sep 2026 11:01:10 -0400

DGX study finds nearly one-third of Lyme-seropositive patients had antibodies to another tick-borne pathogen, highlighting broader testing needs.

Is This the Right Time to Add DGX Stock to Your Portfolio?

Zacks Investment Research · Tue, 22 Sep 2026 09:31:04 -0400

Quest Diagnostics gains momentum from customer wins, advanced diagnostics and AI initiatives, while reimbursement uncertainty, costs and debt pose challenges.

Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges

MarketBeat · Mon, 21 Sep 2026 10:03:12 -0400

Quest Diagnostics NYSE: DGX CEO and President Jim Davis said the diagnostic testing company is exceeding the growth framework it outlined at its prior investor day, driven largely by organic growth, consumer-health demand and partnerships rather than a heavier-than-expected pace of acquisitions.

Market information is provided for research and visualization and is not investment advice.